Smoking as a risk factor for oral candidiasis in HIV-infected adults

Journal of Oral Pathology and Medicine

Volumn 42, Issue 4, 2013, Pages 302-308

  Chattopadhyay, Amit ^a   Patton, Lauren L ^b  

^a NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

Candida; HIV; Interaction; Regression models; Smoking

Indexed keywords

ARTICLE; CD4 LYMPHOCYTE COUNT; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; FOLLOW UP; HAIRY LEUKOPLAKIA; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; INTERVIEW; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MEDICAL RECORD REVIEW; PREDICTION; PRIORITY JOURNAL; QUESTIONNAIRE; RISK FACTOR; SMOKING; THRUSH; UNITED STATES;

ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTI-RETROVIRAL AGENTS; ANTIFUNGAL AGENTS; CANDIDIASIS, ORAL; CD4 LYMPHOCYTE COUNT; COHORT STUDIES; CROSS-SECTIONAL STUDIES; FOLLOW-UP STUDIES; HIV INFECTIONS; HIV SEROPOSITIVITY; HUMANS; INTERVIEWS AS TOPIC; LEUKOPLAKIA, HAIRY; LONGITUDINAL STUDIES; PHYSICAL EXAMINATION; QUESTIONNAIRES; RETROSPECTIVE STUDIES; RISK FACTORS; SMOKING;

EID: 84875809478     PISSN: 09042512     EISSN: 16000714     Source Type: Journal    
DOI: 10.1111/jop.12019     Document Type: Article

References (37)

1. Chattopadhyay A, Caplan DJ, Slade GD, Shugars DC, Tien HC, Patton LL. Incidence of oral candidiasis and oral hairy leukoplakia in HIV-infected adults in North Carolina. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2005; 99: 39-47.
2. Patton LL, McKaig R, Strauss R, Rogers D, Eron JJ Jr. Changing prevalence of oral manifestations of human immuno-deficiency virus in the era of protease inhibitor therapy. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2000; 89: 299-304.
3. Greenspan D, Gange SJ, Phelan JA, et al. Incidence of oral lesions in HIV-1-infected women: reduction with HAART. J Dent Res 2004; 83: 145-50.
4. Yang YL, Lo HJ, Hung CC, Li Y. Effect of prolonged HAART on oral colonization with Candida and candidiasis. BMC Infect Dis 2006; 6: 8.
5. Nittayananta W, Chanowanna N, Winn T. Mode of HIV transmission associated with risk of oral lesions in HIV-infected subjects in Thailand. J Oral Pathol Med 2010; 39: 195-200.
6. Miziara ID, Weber R. Oral candidosis and oral hairy leukoplakia as predictors of HAART failure in Brazilian HIV-infected patients. Oral Dis 2006; 12: 402-7.
7. Patton LL. Sensitivity, specificity, and positive predictive value of oral opportunistic infections in adults with HIV/AIDS as markers of immune suppression and viral burden. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2000; 90: 182-8.
8. Miziara ID, Filho BC, Weber R. Oral lesions in Brazilian HIV-infected children undergoing HAART. Int J Pediatr Otorhinolaryngol 2006; 70: 1089-96.
9. Obuekwe ON, Onunu AN. Gender and oral manifestations of HIV infection among adult Nigerians. Afr J Reprod Health 2006; 10: 81-9.
10. Okoje VN, Obiechina AE, Aken'Ova YA. Orofacial lesions in 126 newly diagnosed HIV/AIDS patients seen at the University College Hospital, Ibadan. Afr J Med Sci 2006; 35: 97-101.
11. Sharma G, Pai KM, Suhas S, Ramapuram JT, Doshi D, Anup N. Oral manifestations in HIV/AIDS infected patients from India. Oral Dis 2006; 12: 537-42.
12. Taiwo OO, Okeke EN, Jalo PH, Danfillo IS. Oral manifestation of HIV/AIDS in Plateau state indigenes, Nigeria. West Afr J Med 2006; 25: 32-7.
13. Van Meter F, Gallo JW, Carcia-Rojas G, Tan MM, Silverman S Jr. A study of oral candidiasis in HIV-positive patients. J Dent Hyg 1994; 68: 30-4.
14. Chattopadhyay A, Gray LR, Patton LL, et al. Salivary secretory leukocyte protease inhibitor and oral candidiasis in human immunodeficiency virus type 1-infected persons. Infect Immun 2004; 72: 1956-63.
15. Soysa NS, Ellepola AN. The impact of cigarette/tobacco smoking on oral candidosis: an overview. Oral Dis 2005; 11: 268-73.
16. Palacio H, Hilton JF, Canchola AJ, Greenspan D. Effect of cigarette smoking on HIV-related oral lesions. J Acquir Immune Defic Syndr Hum Retrovirol 1997; 14: 338-42.
17. Sroussi HY, Villines D, Epstein J, Alves MC, Alves ME. Oral lesions in HIV-positive dental patients - one more argument for tobacco smoking cessation. Oral Dis 2007; 13: 324-8.
18. Masipa JN, Hauman CH, Raubenheimer EJ. Oral carriage of Candida species in patients visiting the Medunsa Dental Clinic. J Dent Assoc S Afr 1992; 47: 407-9.
19. Slavinsky J 3rd, Myers T, Swoboda RK, Leith JE, Hager S, Fidel PL Jr. Th1/Th2 cytokine profiles in saliva of HIV-positive smokers with oropharyngeal candidiasis. Oral Microbiol Immunol 2002; 17: 38-43.
20. Campisi G, Pizzo G, Milici ME, Mancuso S, Margiotta V. Candidal carriage in the oral cavity of human immunodeficiency virus-infected subjects. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2002; 93: 281-6.
21. EEC Clearinghouse on Oral Problems Related to HIV Infection WHO Collaborating Center on Oral Manifestations of the Immunodeficiency. Virus. Classification and diagnostic criteria for oral lesions in HIV infection. J Oral Pathol Med 1993; 22: 289-91.
22. Rothman KJ, Greenland S. Modern epidemiology, 2nd edn. Philadelphia: Lippincott Williams & Wilkins, 1998.
23. Palmer RM, Wilson RF, Hasan AS, Scott DA. Mechanisms of action of environmental factors-tobacco smoking. J Clin Periodontol 2005; 32(Suppl. 6): 180-95.
24. Wallace JM, Oishi JS, Barbers RG, Simmons MS, Tashkin DP. Lymphocytic subpopulation profiles in bronchoalveolar lavage fluid and peripheral blood from tobacco and marijuana smokers. Chest 1994; 105: 847-52.
25. Quinn SM, Zhang JB, Gunsolley JC, Schenkein JG, Schenkein HA, Tew JG. Influence of smoking and race on immunoglobulin G subclass concentrations in early-onset periodontitis patients. Infect Immun 1996; 64: 2500-5.
26. Semlali A, Chakir J, Rouabhia M. Effects of whole cigarette smoke on human gingival fibroblast adhesion, growth, and migration. J Toxicol Environ Health A 2011; 74: 848-62.
27. Banoczy J, Gintner Z, Dombi C. Tobacco use and oral leukoplakia. J Dent Educ 2001; 65: 322-7.
28. Bennet KR, Reade PC. Salivary immunoglobulin A levels in tobacco smokers and patients with minor aphthous ulceration. Oral Surg Oral Med Oral Pathol 1982; 53: 461-5.
29. Berman J, Sudbery PE. Candida albicans: a molecular revolution built on lessons from budding yeast. Nat Rev Genet 2002; 3: 918-30.
30. Brook I. The impact of smoking on oral and nasopharyngeal bacterial flora. J Dent Res 2011; 90: 704-10.
31. Baboni FB, Barp D, Izidoro AC, Samaranayake LP, Rosa EA. Enhancement of Candida albicans virulence after exposition to cigarette mainstream smoke. Mycopathologia 2009; 168: 227-35.
32. Shin ES, Chung SC, Kim YK, Lee SW, Kho HS. The relationship between oral Candida carriage and the secretor status of blood group antigens in saliva. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2003; 96: 48-53.
33. Chiu CT, Li CF, Li JR, et al. Candida invasion and influences in smoking patients with multiple oral leucoplakias-a retrospective study. Mycoses 2011; 54: e377-83.
34. Budtz-Jörgensen E. Etiology, pathogenesis, therapy, and prophylaxis of oral yeast infections. Acta Odontol Scand 1990; 48: 61-9.
35. Mane A, Gaikwad S, Bembalkar S, Risbud A. Increased expression of virulence attributes in oral Candida albicans isolates from human immunodeficiency virus-positive individuals. J Med Microbiol 2012; 61: 285-90.
36. de Azevedo Izidoro AC, Semprebom AM, Baboni FB, et al. Low virulent oral Candida albicans strains isolated from smokers. Arch Oral Biol 2012; 57: 148-53.
37. Lifson AR, Lando HA. Smoking and HIV: Prevalence, Health Risks, and Cessation Strategies. Curr HIV/AIDS Rep 2012; 9: 223-30.